Zydus Lifesciences Limited (ZYDUSLIFE) secures final approval from USFDA for Indocyanine Green for Injection, triggering 180-day CGT exclusivity.
Alembic Pharmaceuticals Limited (APLLTD) reports a 26% YoY revenue surge in Q1 FY27, driven by strong growth in India Branded Business and US Formulation.
Morepen Laboratories Limited (NSE: MOREPENLAB) reports highest-ever quarterly revenue and earnings for Q1 FY27, with EBITDA up 207% and PAT up 394%.
Alivus Life Sciences Limited (ALIVUS) stock price gains 7% intraday, breaking out from its 6M resistance trendline. Current price at ₹1301.0.
Krishna Institute of Medical Sciences Limited (KIMS) announces Q1 FY27 results with revenue up 36% YoY, PAT down 66% YoY.
Discover GPT Healthcare Limited's Q1 FY27 results: Total income up 18% y-o-y, EBITDA up 38.5%, and PAT up 65.7%.
Narayana Hrudayalaya Ltd. (NH) reports a 78% YoY revenue surge and a 7.7% PAT increase in Q1 FY27, highlighting strong financial performance.
Blue Jet Healthcare Limited (BLUEJET) has broken below its support line and is down 5% intraday at ₹593.9.
Divi's Laboratories Limited (NSE: DIVISLAB) stock has cleared its 6-month resistance trendline and is up 5% intraday at ₹8476.0.
Indegene Limited (INDGN) stock breaks out, moving up 5% intraday to ₹541.25, clearing its 6M resistance trendline in the Healthcare sector.